» ABOUT THE COMPANY
Background
How to find us
Licenses and certificates
Patents
Diplomas and awards
Sponsorship
Regional dealers
Partners abroad
» OUR EQUIPMENT
MIL-therapy apparatus «MILTA-F-8-01»
MIL-therapy apparatus «MILTA-F-5-01»
MIL-therapy apparatus «MILTA-F-8-01» with expanded diagnostic properties
EHF-therapy apparatus «EHF-ND»
Terminal for EHF-therapy
EHF-therapy apparatus «Amfit-0.2/10-01»
Price-list
How to purchase
On-line order
» MIL-THERAPY
Basic facts about MIL-therapy
Areas of application
Method of treatment
Publications
Therapy results obtained in medical institutions
Consult the specialist
Reference materials on MIL-therapy
» EHF- THERAPY
Basics of EHF- therapy
Areas of application
Method of treatment
Publications
Reference materials on EHF-therapy
»
REFERENCES
»
QUESTIONS AND ANSWERS
»
CONTACT US
Home
/
MIL-therapy
/
Method of treatment
»Method of treatment
Methodical guidance
Introduction
List of abbreviations and terms
1. Mechanism of biological and therapeutic action produced by low-level IR radiation and light diodes.
2. Mechanism of biological and therapeutic action produced by constant magnetic field (CMF). Magnet-laser therapy ( MIL)
3. Main areas of application for «MILTA-F» instruments.
4. Technical parameters of «MILTA-F»-type devices.
5. Safety measures.
6. Work guidelines.
7. Main principles of MIL- therapy treatment techniques.
7.1. Surgical disorders.
7.2. Acute thrombophlebitis of the extremities.
7.3. Traumatic injuries of long tubular bones, tendons, muscles.
7.4. Disorders of bones and joints of metabolic and inflammatory etiology.
7.5. Disorders of the nervous system. Osteochondrosis. Psychoneurology.
7.6. Atherosclerotic injuries of arteries in the lower extremities.
7.7. Diseases of the gastro-intestinal tract.
7.8. Cardio-vascular pathology.
7.9. Inflammatory diseases in the bronchi and lungs.
7.10. Gynecological disorders.
7.11. Urology.
7.12. Endocrine disorders.
7.13. Chronical anemias.
7.14. Dermatological disorders.
7.15. Otolaryngological (ENT) pathology.
7.16. Stomatology.
8. Biophotometry as a mean of control over MIL-therapy.
9. Conclusion.
Annex
